Derivatives of pyrido[2,3-d]pyrimidine, the preparation...

Details Derivatives of pyrido[2,3-d]pyrimidine, the preparation... Derivatives of pyrido[2,3-d]pyrimidine, the preparation...

2011-08-30

2011-08-30

Wilson, James O (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C544S279000

Reexamination Certificate

active

08008310

ABSTRACT:
Derivatives of pyrido[2,3-d]pyrimidine are provided having formula (I)with Ar1, Ar2and R1as defined herein, which are useful for treating cell proliferative conditions, and to the preparation thereof, and to the therapeutic application of the same.

REFERENCES:
patent: 3534039 (1970-10-01), Davoll
patent: 5620981 (1997-04-01), Blankley et al.
patent: 5733913 (1998-03-01), Blankley et al.
patent: 5733914 (1998-03-01), Blankley et al.
patent: 5952342 (1999-09-01), Blankley et al.
patent: 7714151 (2010-05-01), Kelly et al.
patent: 2007/0167469 (2007-07-01), Bourrie et al.
patent: 2009/0253696 (2009-10-01), Herdewijn et al.
patent: 0 790 997 (2000-03-01), None
patent: WO 96/15128 (1996-05-01), None
patent: WO 96/34867 (1996-11-01), None
patent: WO 01/55147 (2001-08-01), None
patent: WO 01/70741 (2001-09-01), None
patent: WO 02/12238 (2002-02-01), None
patent: WO 03/000011 (2003-01-01), None
patent: WO 2004/063195 (2004-07-01), None
patent: WO 2004/085436 (2004-10-01), None
patent: WO 2005/105097 (2005-11-01), None
patent: WO 2006/016067 (2006-02-01), None
patent: WO 2007/080324 (2007-07-01), None
Griesser, Chapter 8, The Importance of Solvates (pp. 211-230), Polymorphism: In the Pharmaceutical Industry, Hilfiker, 2006.
Britain, <http://www.netlibrary.com
lreader.dll?bookid=12783&filename=Page—126.html>, pp. 126-127, 2008.
U.S. Appl. No. 12/166,431, filed Jul. 2, 2008, Perreaut et al.
Alam, Fighting Cancer: ‘Magic Bullets’ on Target to Lead Market, Pharmalicensing.com (Mar. 8, 2005).
Anzali et al, 1. Endothelin antagonists: Search for Surrogates of Methylendioxyphenyl by Means of a Kohonen Neural Network, Bioorganic & Medicinal Chemistry Letters 8 (1998) pp. 11-16.
Lewell et al, Drug Rings Database with Web Interface. A Tool for Identifying Alternative Chemical Rings in Lead Discovery Programs, J. Med. Che. 2003, 46, pp. 3257-3274.
Mederski et al, 2. Endothelin Antagonists: Evaluation of 2,1,3-Benzothiadiazole as a Methylendioxyphenyl Bioisoster, Bioorganic & Medicinal Chemistry Letters 8 (1998) pp. 17-22.
Palmer et al, Structure-activity Relationships for 2-anilino-6-phenylpyrido[2,3-d]pyrimidin-7(8H)-ones as Inhibitors of the Cellular Checkpoint Kinase Wee1, Bioorganic & Medicinal Chemistry Letters 15 (2005) pp. 1931-1935.
Schroeder et al, Soluble 2-Substituted Aminopyrido[2,3-d]pyrimidin-7-yl Ureas. Structure—Activity Relationships against Selected Tyrosine Kinases and Exploration of in Vitro and in Vivo Anticancer Activity, J. Med. Chem. 2001, (44), 1915-1926.
Sicinski, Killer Breast Cancer Therapy Hope, BBC News/Health Jan. 21, 2006.
Thompson et al, Synthesis and Structure—Activity Relationships of Soluble 7-Substituted 3-(3,5-Dimethoxyphenyl)-1,6-naphthyridin-2-amines and Related Ureas as Dual Inhibitors of the Fibroblast Growth Factor Receptor-1 and Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinases, J. Med. Chem. 2005, (48), 4628-4653.
Walsh, No ‘Magic Bullet’ Cure for Cancer, BBC News, International Version, Medical Notes, Feb. 1, 2007.

Affiliated with

Also associated with

Rating

Derivatives of pyrido[2,3-d]pyrimidine, the preparation... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Derivatives of pyrido[2,3-d]pyrimidine, the preparation..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of pyrido[2,3-d]pyrimidine, the preparation... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2742807